Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Xeris Pharmaceuticals
Xeris Pharmaceuticals
(XERS)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Keveyis
Dichlorphenamide
1982-01-01
Glaucoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Glucagon
healthy volunteers/patients
,
common cold
,
insulin resistance
,
hypersensitivity
,
liver diseases
,
diabetes complications
,
hypoglycemia
,
type 1 diabetes mellitus
,
overweight
,
hyperglycemia
,
glucose metabolism disorders
,
metabolic diseases
,
metabolic syndrome
,
endocrine system diseases
,
weight loss
,
chronic renal insufficiency
,
kidney diseases
,
cardiovascular diseases
,
left ventricular dysfunction
,
coronary artery disease
,
type 2 diabetes mellitus
,
diabetes mellitus
,
obesity
,
fatty liver
,
body weight
,
weight gain
,
glucose intolerance
,
non-alcoholic fatty liver disease
,
knee osteoarthritis
,
osteoarthritis
,
carcinoma
,
thyroid neoplasms
,
neuroendocrine carcinoma
,
papillary thyroid cancer
,
thyroid diseases
,
diabetic nephropathies
,
inflammation
,
pancreatitis
,
hyperlipidemias
,
peripheral nervous system diseases
,
diabetic neuropathies
Insulin
hypoglycemia
,
congenital hyperinsulinism
,
nesidioblastosis
,
breast neoplasms
,
obesity
,
triple negative breast neoplasms
,
polycystic ovary syndrome
,
overweight
,
prediabetic state
,
hypersensitivity
,
type 1 diabetes mellitus
,
type 2 diabetes mellitus
,
diabetes mellitus
,
insulin resistance
,
hypertension
,
glucose intolerance
,
acromegaly
,
metabolic syndrome
,
syndrome
,
prehypertension
,
hyperglycemia
,
pituitary acth hypersecretion
,
acth-secreting pituitary adenoma
,
neuroendocrine tumors
Viaject
diabetes mellitus
,
type 1 diabetes mellitus
,
type 2 diabetes mellitus
Pram9
diabetes mellitus
,
type 1 diabetes mellitus
Pancreatin
type 1 diabetes mellitus
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use